Watchlist Price Alert

Marinus Pharmaceuticals I... (MRNS)

NASDAQ: MRNS · Real-Time Price · USD

0.55

0.00 (0.00%)

At close: Feb 10, 2025, 3:59 PM

Marinus Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	120.57M	240.55M	122.93M	138.51M	90.94M	67.73M	33.53M	26.18M
Short-Term Investments	29.72M	n/a	n/a	1.47M	739K	5M	19.86M	3.92M
Long-Term Investments	n/a	n/a	n/a	1.47M	n/a	n/a	24.82M	n/a
Other Long-Term Assets	819K	14.73M	11.41M	6.89M	2.44M	n/a	978K	n/a
Receivables	3.8M	6.35M	3.19M	1.65M	n/a	n/a	n/a	n/a
Inventory	2.41M	77K	-9.31M	-6.28M	n/a	n/a	n/a	n/a
Other Current Assets	8.75M	5.4M	n/a	n/a	2.45M	1.22M	978K	199K
Total Current Assets	165.25M	240.55M	122.93M	140.16M	94.13M	73.94M	33.53M	30.3M
Property-Plant & Equipment	4.84M	4.24M	2.5M	1.95M	2.27M	1.29M	1.34M	1.15M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.66M	18.97M	13.91M	10.31M	4.71M	1.29M	27.14M	1.15M
Total Assets	170.91M	259.52M	136.84M	150.46M	98.84M	75.23M	60.67M	31.45M
Account Payables	4M	4.46M	3.13M	2.21M	2.76M	2.47M	927K	2.81M
Deferred Revenue	n/a	n/a	15.65M	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	13.76M	1.02M	n/a	n/a	n/a	n/a	n/a	3.5M
Other Current Liabilities	n/a	2.44M	21.23M	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	40.62M	54.87M	40.57M	10.73M	8.03M	6.91M	2.54M	8.08M
Long-Term Debt	95.19M	71.02M	40.81M	n/a	n/a	n/a	n/a	1.74M
Other Long-Term Liabilities	152K	29.86M	n/a	n/a	n/a	n/a	120K	141K
Total Long-Term Liabilities	113.52M	88.64M	42.79M	2.53M	3.04M	n/a	120K	1.88M
Total Liabilities	154.14M	143.52M	83.35M	13.26M	11.07M	6.91M	2.66M	9.97M
Total Debt	110.36M	72.67M	40.81M	510K	446K	n/a	n/a	5.24M
Common Stock	55K	50K	37K	37K	87K	53K	41K	20K
Retained Earnings	-571.93M	-430.52M	-410.7M	-311.93M	-235.57M	-181.45M	-144.73M	-125.83M
Comprehensive Income	-20K	n/a	n/a	-0.00	0.00	-2K	-96K	-358K
Shareholders Equity	16.77M	116M	53.49M	137.2M	87.77M	68.33M	58.01M	21.48M
Total Investments	29.72M	n/a	n/a	2.95M	739K	5M	24.82M	3.92M